Palabras clave
Hipertensión
COVID-19
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: Analizar los impactos de la COVID-19 en el tratamiento de la hipertensión arterial sistémica. Revisión bibliográfica: Los impactos directos de COVID-19 en el sistema cardiovascular incluyen el empeoramiento de la hipertensión y las complicaciones asociadas. El aislamiento social redujo la adherencia al tratamiento, aumentó el estrés y alteró los hábitos de vida, como la dieta y el ejercicio, contribuyendo al descontrol de la presión arterial. Además, el acceso a los servicios de salud se vio comprometido, especialmente para los grupos socioeconómicamente desfavorecidos, aumentando las disparidades en salud. La telemedicina emergió como una solución viable, pero su implementación fue desigual. La incidencia de trastornos hipertensivos del embarazo (HDP) aumentó significativamente en 2020, con la cuarentena asociada con mayor aumento de peso gestacional, tasas de obesidad, presión arterial elevada y niveles de ácido úrico. Consideraciones finales: Las estrategias de intervención en la Atención Primaria de Salud, como la educación remota y el apoyo social, son esenciales para enfrentar los desafíos de la pandemia y promover mejores resultados de salud para los pacientes con hipertensión.
Referencias
ALTENA E, et al. Dealing with sleep problems during home confinement due to the COVID-19 outbreak: Practical recommendations from a task force of the European CBT-I Academy. Journal of sleep research, 2020; 29(4): e13052.
AMANCIO ADM, et al. Telemonitoramento dos idosos de natal-rn na atenção primária durante a pandemia da covid-19: estudo longitudinal descritivo. Rev. Ciênc. Plur, 2023, 33526-33526.
BROOKS S, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet, 2020; 395(10227): 912–920.
CAI Q, et al. Home Quarantine: A Double-Edged Sword During COVID-19 Pandemic for Hypertensive Disorders of Pregnancy and the Related Complications. Diabetes, metabolic syndrome and obesity: targets and therapy, 2022;15: 2405–2415.
DA CONCEIÇÃO EM, et al. A percepção do enfermeiro na atenção básica em relação a adesão ao tratamento anti-hipertensivo com idosos em meio a pandemia do Covid-19 em um Município no interior de Pernambuco. Brazilian Journal of Development, 2021; 7(7): 75330-75343.
DA SILVA WBH, et al. O que a pandemia da COVID-19 fez com a pressão arterial sistêmica?. Global Academic Nursing Journal, 2021; 2(Spe. 2): e105-e105.
DE ALMEIDA GC, et al. Nova Geração da Telessaúde: Oportunidades, Tendências e Desafios. Sociedade Brasileira de Computação, 2023.
DERINGTON CG, et al. Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans. PLoS One, 2021;16(4): e0248080.
DI RENZO L, et al. Eating habits and lifestyle changes during COVID-19 lockdown: an Italian survey. Journal of translational medicine, 2020; 18(1): 229.
EMAMI A, et al. Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis. Archives of academic emergency medicine, 2020; 8(1): e35.
GALINDO LLD, et al. Estratégia de saúde da família: métodos para captação e manutenção de pacientes na atenção básica. Brazilian Journal of Health Review, 2024; 7(2): e67774-e67774.
GARFAN S, et al. Telehealth utilization during the Covid-19 pandemic: A systematic review. Computers in biology and medicine, 2021; 38: 104878.
GOLD R, et al. Cardiovascular Disease Risk Management During COVID-19: In-Person vs Virtual Visits. American Journal of Managed Care, 2024; 30(1).
GUZIK TJ, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options, Cardiovascular Research, 2020; 116(10): 1666–1687.
HARTNETT K, et al. Impact of the COVID-19 Pandemic on Emergency Department Visits - United States, January 1, 2019-May 30, 2020. MMWR, 2020; 69(23): 699–704.
HOOPER MW, et al. COVID-19 and Racial/Ethnic Disparities. JAMA. 2020;323(24):2466–2467.
KORVES C, et al. Hypertension Control During the Coronavirus Disease 2019 Pandemic: A Cohort Study Among US Veterans. Medical care, 2024; 62(3): 196-204.
MEHTA B, et al. Hydroxychloroquine and Chloroquine in COVID-19: A Survey of Prescription Patterns Among Rheumatologists. J Clin Rheumatol, 2020; 26(6): 224-228.
MELERO FILHO CAL. Estrutura de personalidade e sucesso profissional: uma revisão de literatura nos últimos quinze anos. A Saúde Pública e o Bem-Estar da Sociedade 2, 2023: p. 59.
PALMER K, et al. The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing. Aging clinical and experimental research, 2020; 32(7):1189–1194.
PALOSKI GDR, et al. Contribuição do telessaúde para o enfrentamento da COVID-19. Escola Anna Nery,2020;24.
PASSOS HD, et al. SARS-Cov-2 Infection and Pulmonary Thromboembolism - The Prothrombotic State in COVID-19. Arq Bras Cardiol, 2020;115(1): 142-145.
RAIFMAN MA e RAIFMAN JR. Disparities in the Population at Risk of Severe Illness From COVID-19 by Race/Ethnicity and Income. Am J Prev Med, 2020; 59(1): 137-139.
SCHOLZ JR, et al. COVID-19, Renin-Angiotensin System, Angiotensin-Converting Enzyme 2, and Nicotine: What is the Interrelation? Arq Bras Cardiol, 2020; 115(4):708-711.
SMITH AC, et al. Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19). Journal of telemedicine and telecare, 2020; 26(5): 309–313.
WANG S, et al. Association of social isolation and loneliness with the risk of hypertension in middle aged and older adults: Findings from a national representative longitudinal survey. Journal of Affective Disorders, 2024;349: 577-582.
ZHOU F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England), 2020; 395(10229): 1054–1062.